108 related articles for article (PubMed ID: 3156820)
1. Induction of class II (Ia) alloantigen expression on corneal endothelium in vivo and in vitro.
Donnelly JJ; Li WY; Rockey JH; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):575-80. PubMed ID: 3156820
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells.
Iwata M; Yagihashi A; Roat MI; Zeevi A; Iwaki Y; Thoft RA
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):3991-4000. PubMed ID: 7960581
[TBL] [Abstract][Full Text] [Related]
3. Class II alloantigen induced on corneal endothelium. Role in corneal allograft rejection.
Donnelly JJ; Orlin SE; Wei ZG; Raber IM; Rockey JH
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1315-20. PubMed ID: 2194989
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
5. A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma.
Donnelly JJ; Xi MS; Rockey JH
Exp Eye Res; 1993 Feb; 56(2):157-65. PubMed ID: 8462649
[TBL] [Abstract][Full Text] [Related]
6. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
[TBL] [Abstract][Full Text] [Related]
7. Endothelial and smooth muscle cells in the heart allograft response: isolation procedure and immunocytochemical features.
Wijngaard PL; de Bresser JM; de Groot PG; Gmelig-Meyling FH; Schuurman HJ; Jambroes G; Borleffs JC
J Heart Lung Transplant; 1991; 10(3):416-23. PubMed ID: 1830221
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus induces class II expression in rat heart endothelial cells.
Ustinov JA; Loginov RJ; Bruggeman CA; van der Meide PH; Häyry PJ; Lautenschlager IT
J Heart Lung Transplant; 1993; 12(4):644-51. PubMed ID: 8396436
[TBL] [Abstract][Full Text] [Related]
9. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
Young E; Stark WJ; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
[TBL] [Abstract][Full Text] [Related]
10. Modulation of HLA antigen expression on corneal epithelial and stromal cells.
Dreizen NG; Whitsett CF; Stulting RD
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):933-9. PubMed ID: 3131265
[TBL] [Abstract][Full Text] [Related]
11. In vivo induction of Ia expression in murine cornea after intravitreal injection of interferon-gamma.
Brandt CR; Knupfer PB; Boush GA; Gausas RE; Chandler JW
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2248-53. PubMed ID: 2122962
[TBL] [Abstract][Full Text] [Related]
12. Anterior chamber-associated immune deviation promotes corneal allograft survival.
Niederkorn JY; Mellon J
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility class II expression in the normal canine cornea and in canine chronic superficial keratitis.
Williams DL
Vet Ophthalmol; 2005; 8(6):395-400. PubMed ID: 16359362
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
15. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ia antigen by ocular tissues of mice treated with interferon gamma.
Kusuda M; Gaspari AA; Chan CC; Gery I; Katz SI
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):764-8. PubMed ID: 2467889
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
18. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ia antigen-like molecules on cells in the corneal epithelium.
Klareskog L; Forsum U; Tjernlund UM; Rask L; Peterson PA
Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):310-3. PubMed ID: 370058
[TBL] [Abstract][Full Text] [Related]
20. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms.
Watson CA; Petzelbauer P; Zhou J; Pardi R; Bender JR
J Immunol; 1995 Apr; 154(7):3222-33. PubMed ID: 7897208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
